肝细胞癌中葡萄糖载体蛋白的研究进展
Zheng Ruan1, Yan Wang2, Lei Shi3
1The First Clinical Medical School, Gansu University of Chinese Medicine, Lanzhou 730000, Gansu Province, China.
World journal of hepatology
|April 3, 2025
概括
葡萄糖载体蛋白 (GLUT) 在肝细胞癌 (HCC) 进展中至关重要. 用抑制剂向GLUT显示出通过减少瘤生长和提高化疗有效性来治疗HCC的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的全球癌症,死亡率高.
- 癌细胞经历代谢重编程,显著影响瘤的进展.
- 葡萄糖载体蛋白 (GLUTs) 是细胞葡萄糖吸收和新陈代谢的关键促进者.
研究的目的:
- 审查目前关于HCC中GLUTs的研究.
- 探索GLUT在HCC中的表达模式,功能和治疗潜力.
- 突出GLUTs在HCC攻击性,代谢重编程和患者预后中的作用.
主要方法:
- 对肝细胞癌中GLUT研究的文献综述.
- 分析GLUT在HCC中的表达模式和功能作用.
- 在HCC模型中对GLUT抑制剂的临床前数据的评估.
主要成果:
- 在HCC中GLUT表达水平与瘤的攻击性,代谢重编程和预后相关.
- 实验室和体内研究表明,GLUT抑制剂减少HCC细胞生长和葡萄糖吸收.
- GLUT抑制剂显示出阻碍瘤生长和增强化学敏感性的潜力.
结论:
- GLUT在HCC的发展和进展中发挥着重要作用.
- 针对GLUTs代表了HCC的一个有前途的治疗策略.
- 需要进一步的研究来将GLUT向疗法转化为HCC治疗的临床实践.
相关概念视频
01:27Glucose Transporters
22.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
01:26Glucose Absorption Into the Small Intestine
31.0K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
31.0K